Medline ® Abstract for Reference 77
of 'Toxicities associated with checkpoint inhibitor immunotherapy'
77
TI
Immune-mediated red cell aplasia after anti-CTLA-4 immunotherapy for metastatic melanoma.
AU
Gordon IO, Wade T, Chin K, Dickstein J, Gajewski TF
SO
Cancer Immunol Immunother. 2009;58(8):1351. Epub 2008 Dec 4.
AD
PMID